Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Biomed Research International|December 27, 2013
The effect of apigenin on pharmacokinetics of imatinib and its metabolite N-desmethyl imatinib in ratsXian-yun Liu, Tao Xu, Wan-shu Li, et al.
Drug Development and Industrial Pharmacy|August 22, 2014
Effect of CYP2C9 genetic polymorphism on the metabolism of flurbiprofen in vitroLi Wang, Shi-Hui Bao, Pei-Pei Pan, et al.
Drug Metabolism and Pharmacokinetics|March 28, 2016
Effect of CYP2D6 genetic polymorphism on the metabolism of citalopram in vitroXiao-Xia Hu, Ling-Jing Yuan, Ping Fang, et al.
Frontiers in Pharmacology|March 1, 2021
Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a PatientXiao-Yang Zhou, Xiang-Ran Lu, Ying-Hui Li, et al.
Drug Development and Industrial Pharmacy|January 12, 2019
Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in ratsDan Lou, Xiao Cui, Su-Su Bao, et al.
International Journal of Clinical Pharmacology and Therapeutics|July 3, 2014
Drug-drug interaction of losartan and glimepiride metabolism by recombinant microsome CYP2C9*1, 2C9*3, 2C9*13, and 2C9*16 in vitroSai-Zhen Chen, Pei-Pei Pan, Lei-Bin Shen, et al.
Basic & Clinical Pharmacology & Toxicology|December 4, 2014
In vitro functional assessment of 22 newly identified CYP2D6 allelic variants in the Chinese populationDa-Peng Dai, Pei-Wu Geng, Shuang-Hu Wang, et al.
Oxidative Medicine and Cellular Longevity|December 5, 2017
Increased Oxidative Damage of RNA in Early-Stage Nephropathy in db/db MiceWan-Xia Wang, Shun-Bin Luo, Ping Jiang, et al.
Pharmacogenomics|November 15, 2012
Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han populationLi-Ming Hu, Da-Peng Dai, Guo-Xin Hu, et al.
Pharmacology|June 12, 2016
Inhibitory Effect of Apigenin on Losartan Metabolism and CYP2C9 Activity in vitroZhe Wang, Yun Gong, Da-Li Zeng, et al.
Pageof 14